Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Gaussia Luciferase Antibody (SAA1380)

Catalog #:   RXX52501 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA
Accession: AAG54095.1
Overview

Catalog No.

RXX52501

Species reactivity

Gaussia princeps

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

Luciferase

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

AAG54095.1

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1380

Data Image
References

Construction of an Integration Vector with a Chimeric Signal Peptide for the Expression of Monoclonal Antibodies in Mammalian Cells., PMID:39727996

Durable transgene expression and efficient re-administration after rAAV2.5T-mediated fCFTRΔR gene delivery to adult ferret lungs., PMID:38638546

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily., PMID:37051245

A Recombinant Genotype I Japanese Encephalitis Virus Expressing a Gaussia Luciferase Gene for Antiviral Drug Screening Assay and Neutralizing Antibodies Detection., PMID:36555192

A luciferase based automated assay for rapid and sensitive detection of SARS-CoV-2 antibodies., PMID:36464447

Development of a highly sensitive Gaussia luciferase immunoprecipitation assay for the detection of antibodies against African swine fever virus., PMID:36189357

Recombinant Spider Silk Bioinks for Continuous Protein Release by Encapsulated Producer Cells., PMID:36067476

A Recombinant Porcine Reproductive and Respiratory Syndrome Virus Stably Expressing a Gaussia Luciferase for Antiviral Drug Screening Assay and Luciferase-Based Neutralization Assay., PMID:35633700

Processing and Subcellular Localization of the Hepatitis E Virus Replicase: Identification of Candidate Viral Factories., PMID:35283856

High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles., PMID:35215941

A Recombinant System and Reporter Viruses for Papiine Alphaherpesvirus 2., PMID:35062295

Inhibitory activity of limonoids from Khaya grandifoliola C.DC (Meliaceae) against hepatitis C virus infection in vitro., PMID:34290967

Seroprevalence of severe fever with thrombocytopenia syndrome virus in animals in Kagoshima Prefecture, Japan, and development of Gaussia luciferase immunoprecipitation system to detect specific IgG antibodies., PMID:34218054

Non-primate hepacivirus transmission and prevalence: Novel findings of virus circulation in horses and dogs in Morocco., PMID:34175479

Development and Characterization of a Highly Sensitive NanoLuciferase-Based Immunoprecipitation System for the Detection of Anti-Influenza Virus HA Antibodies., PMID:33980684

Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model., PMID:33905019

NanoLuc luciferase as a suitable fusion partner of recombinant antibody fragments for developing sensitive luminescent immunoassays., PMID:33896564

Structure-based Design of a Specific, Homogeneous Luminescence Enzyme Reporter Assay for SARS-CoV-2., PMID:33839165

Constitutively active Rheb mutants [T23M] and [E40K] drive increased production and secretion of recombinant protein in Chinese hamster ovary cells., PMID:33694218

Toolkit for Quickly Generating and Characterizing Molecular Probes Specific for SARS-CoV-2 Nucleocapsid as a Primer for Future Coronavirus Pandemic Preparedness., PMID:33534552

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors., PMID:33035201

Construction and immune protection evaluation of recombinant virus expressing Newcastle disease virus F protein by the largest intergenic region of fowlpox virus NX10., PMID:33009986

Bioluminescent detection of zearalenone using recombinant peptidomimetic Gaussia luciferase fusion protein., PMID:32886242

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors: a cohort study using a rapid and sensitive high-throughput neutralization assay., PMID:32793931

Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus Infections., PMID:32159399

Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection., PMID:31685871

Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Gaussia Luciferase., PMID:31330768

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate., PMID:31305532

Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles., PMID:30943406

Determination of neutralization activities by a new versatile assay using an HIV-1 genome carrying the Gaussia luciferase gene., PMID:30817948

Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells., PMID:30524448

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model., PMID:30333914

A Bioluminescent Cell Assay to Quantify Prion Protein Dimerization., PMID:30242186

Large-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread., PMID:30223489

HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses., PMID:29966356

Seroprevalence of Toxoplasma gondii in free-ranging and feral cats on Amami Oshima Island, Japan., PMID:28966212

Construction and characterization of a recombinant yellow fever virus stably expressing Gaussia luciferase., PMID:28746549

Bioorthogonal Protein Conjugation: Application to the Development of a Highly Sensitive Bioluminescent Immunoassay for the Detection of Interferon-γ., PMID:28514139

Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling., PMID:28472300

Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy., PMID:28167276

Quantitative analysis of cell surface antigen-antibody interaction using Gaussia princeps luciferase antibody fusion proteins., PMID:28095113

A two-step screening approach for the identification of blood donors with highly and broadly neutralizing capacities against human cytomegalovirus., PMID:27861998

The Functionality of Minimal PiggyBac Transposons in Mammalian Cells., PMID:27701401

Gaussia Luciferase as a Genetic Fusion Partner with Antibody Fragments for Sensitive Immunoassay Monitoring of Clinical Biomarkers., PMID:26625180

High-efficiency secretory expression of human neutrophil gelatinase-associated lipocalin from mammalian cell lines with human serum albumin signal peptide., PMID:26518367

Generation of a recombinant West Nile virus stably expressing the Gaussia luciferase for neutralization assay., PMID:26415755

Selenocystamine improves protein accumulation in chloroplasts of eukaryotic green algae., PMID:26137911

Genetic and serological surveillance for non-primate hepacivirus in horses in Japan., PMID:26070772

Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation., PMID:25855727

Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies., PMID:24957778

Datasheet
$ 130
Product specifications
50 μg 130 100 μg 220

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Gaussia Luciferase Antibody (SAA1380) [RXX52501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only